Selection and prioritization of candidate combination regimens for the treatment of tuberculosis.
Europe PMC REST API · 学术索引收录 · 来源发布：Wed Feb 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:07:53 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Accelerated tuberculosis drug discovery has increased the number of plausible multidrug regimens. Testing every drug combination in vivo is impractical, and varied experimental conditions make it challenging to compare results between experiments. Using published treatment efficacy data from a mouse tuberculosis model treated with candidate combination regimens, we trained and externally validated
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。